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Cyclopia is characterized by the presence of a single eye, with varying degrees of doubling of the intrinsic ocular
structures, located in the middle of the face. It is the severest facial expression of the holoprosencephaly (HPE)
spectrum. This study describes the prevalence, associated malformations, and maternal characteristics among
cases with cyclopia. Data originated in 20 Clearinghouse (ICBDSR) affiliated birth defect surveillance systems,
reported according to a single pre-established protocol. A total of 257 infants with cyclopia were identified.
Overall prevalence was 1 in 100,000 births (95%CI: 0.89–1.14), with only one program being out of range.
Across sites, there was no correlation between cyclopia prevalence and number of births (r¼ 0.08; P¼ 0.75) or
proportion of elective termination of pregnancy (r¼0.01; P¼ 0.97). The higher prevalence of cyclopia among
oldermothers (older than 34) was not statistically significant. Themajority of caseswere liveborn (122/200; 61%)
and females predominated (male/total: 42%). A substantial proportion of cyclopias (31%) were caused by
chromosomal anomalies, mainly trisomy 13. Another 31%of the cases of cyclopias were associated with defects
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not typically related to HPE, with more hydrocephalus, heterotaxia defects, neural tube defects, and preaxial
reduction defects than the chromosomal group, suggesting the presence of ciliopathies or other unrecognized
syndromes. Cyclopia is a very rare defect without much variability in prevalence by geographic location. The
heterogeneous etiology with a high prevalence of chromosomal abnormalities, and female predominance
in HPE, were confirmed, but no effect of increased maternal age or association with twinning was observed.
2011 Wiley Periodicals, Inc.
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INTRODUCTION
‘‘Cyclopia is a congenital malfor-
mation characterized by the pres-
ence of a single eye, which usually
manifests various degrees of dou-
bling of intrinsic structures, located
in the middle of the face in the
place normally occupied by the
root of the nose.’’
With this elegant definition Sedano
and Gorlin began their 1963 article
about the oral manifestation of cyclopia,
reporting two cyclopia patients and a
literature review about the specific
manifestations of cyclopia that deserves
an actual reading because of its com-
pleteness. Holoprosencephaly (HPE)
was also reviewed in extenso in a special
issue of Part C in the American Journal of
Medical Genetics [Muenke et al., 2010].
Thus only new pertinent information
will be included here.
Usually considered as the severest
gradation of facial malformation associ-
ated with HPE, cyclopia rarely is
presented separately from other HPE
types. Cyclopia by itself appeared in the
epidemiological work of Ka¨lle´n et al.
[1992], in the chapter in a more general
work about HPE [Cohen and Sulik,
1992], and among few median anoma-
lies in the interpretative work of
O’Railly and Mu¨ller [1989]. However,
there are hundreds of case reports of
cyclopia in humans and in other verte-
brates, besides the experimental studies
in animal models causing cyclopia. This
vast amount of case reports in the
literature on cyclopia allows us to have
an exact idea about the phenotypic
variation and possible etiologies of this
condition. The rarity of the condition,
however, does not allow epidemiolo-
gical studies to demonstrate the risk
factors and the contribution of each
one to the onset of cyclopia. Using
material registered by theClearinghouse
[ICBDSR, 2009] frommillions of births
surveyed by 20 surveillance programs
worldwide, our aimhere is to analyze the
prevalence and possible risk factors of
cyclopia.
Historical Aspects
Recent reviews of teratology and myth-
ology by Cohen [2010b], and by Stahl
and Tourame [2010] agreed with pre-
vious reviewers that real newborns with
those defects existed in the origin of the
mythological creatures and fantastic
beings. Although there is no way to be
sure of the population number at
the year 800 BC in all the world, an
educated guess suggested 66,000,000
[Mc Evedy and Jones, 1978], and
another guess suggested a crude birth
rate of 80 per 1,000 for this period
(http://www. prb.org/Articles/2002/
HowManyPeopleHaveEverLivedonEarth.
aspx). If so, around the timeOdysseywas
being composed, approximately 53 cases
of cyclopia were born by year, in the
world population. We can speculate on
how this small number of cases could
have caused such an impressive impact
on the people’s imagination. One pos-
sibility is that in those earlier times, the
prevalence of cyclopia was higher than it
is now. There are many other possibil-
ities as there are scholarly theories of the
myths. The study of the origin of the
myths probably requires tools fromother
fields such as anthropology, psychology,
sociology, or semiology.
Normal and Abnormal
Development
As part of the HPE spectrum, the
prosencephalon in cyclopia cases fails
to develop into two hemispheres
[Cohen and Sulik, 1992]. Although
HPE is usually divided into alobar,
semilobar, and lobar types according to
severity, to the presence or not of the
interhemispheric fissure and the extent
of separation of both hemispheres
[DeMyer and Zeman, 1963], cyclopia
presents almost always as the alobar type.
Only few instances of semi-lobar HPE
were found in the literature [Orioli and
Castilla, 2007; Dane et al., 2009]. In the
alobar type there is complete or near
complete lack of interhemispheric sep-
aration, single midline forebrain ven-
tricle, absent interhemispheric fissure,
falx cerebri, olfactory bulbs, and corpus
callosum; and nonseparation of deep
gray nuclei, as summarized in the HPE
flashcards produced by Solomon et al.
[2010]. Also published were detailed
aspects on early pathogenesis [Shiota and
Yamada, 2010], neuropathology [Hahn
and Barnes, 2010], and neuroimaging
[Marcorelles and Laquerriere, 2010].
In 1963, Sedano and Gorlin pre-
sented the discussion between two
apparently conflicting theories, among
others, to explain the pathogenesis of
cyclopia. In one theory the condition is
said to be caused by abnormal differenti-
ation of the prochordal mesoderm in the
central part of the developing head
region. Another hypothesis states that
the brain malformation is the primary
anomaly. Today, it is clear that both are
involved but one of the key signaling
centers for the pathogenesis of HPE is
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the most anterior extent of the midline
mesoderm, called the prechordal
plate. Several signals emanate from the
prechordal plate and trigger a secondary
patterning center in the ventral
forebrain. Two complete reviews
[Klingensmith et al., 2010; Roessler
and Muenke, 2010] show that the
requirement for delicate balancing of
numerous key influences includes
hedgehogs, fibroblast growth factors
(Fgfs), bone morphogenic proteins
(Bmps), retinoic acid, and canonical and
noncanonicalWnt signaling.
England et al. [2006] labeled every
cell nuclei of zebra-fish embryos with
green fluorescent protein to visualize
and track their movements and pro-
duced a dynamic fate map of the
forebrain showing how the vertebrate
eyes form. The authors also tested
zebrafish embryos with two different
mutations causing cyclopia showing that
cyclopia in Cyclops (loss ofNdr2) results
in incorporation of eye tissue into an
inappropriate locationwithin themedial
neural keel (an intermediate stage be-
tween the neural plate and neural rod
during the early segmentation period in
the morphogenesis of the central ner-
vous system primordium); the much
reduced convergent and forward move-
ment of lateral-posterior eye-field cells
fated to the optic stalk in Silberblick
cyclopia mutants (loss of Wnt11) results
in medial-posterior eye-field cells
remaining medial. These two defects of
forebrain morphogenesis are temporally
and spatially distinct pointing to the
recognized etiologic heterogeneity of
cyclopia.
Genetics and Clinical Genetics
Cyclopia is an etiologically heteroge-
neous condition, which can result from
chromosomal defects, genetic muta-
tions, or environmental teratogenic fac-
tors. Several important reviews address
the HPE etiology, mostly by MMichael
Cohen Jr., but also by Maximilian
Muenke, and by Sylvie Odent and
Veronique David groups. In general
there is little information about the
etiology of cyclopia specifically in those
reviews because cyclopia is considered to
be the severest form of HPE [Cohen,
1989a; Muenke and Beachy, 2000;
Dubourg et al., 2007].
Trisomy 13 is the most common
chromosomal disorder associated with
HPE. The trisomies 18 and 21 have also
been described, as well as triploidy. The
structural abnormalities described in the
literature on 11 different chromosomes
allowed the identification of 12 loci for
HPE [Roessler and Muenke, 1998].
These loci are called HPE1 to HPE12
and are located in regions 21q33.3, 2p21
(SIX3), 7q36 (SHH), 18p11.3 (TGIF),
13q32 (ZIC2), 2q371–q37.3, 9q22.3
(PTCH1), prox 14q, 20p13, 1q42-qter
(DISP1), 5pter, and 6q26-qter
[Dubourg et al., 2007]. Only six genes
(in parentheses) were assigned to the loci
HPE2, HPE3, HPE4, HPE5, HPE7,
and HPE10. There are no genes
reported yet for the other six loci.
Cohen [2006, 2010a] presented com-
plete reviews including other genes
associated with HPE; however, only
the Smith–Lemli–Opitz syndrome
gene, DHCR7 on 11q12–q13, was, in
the literature, associated with cyclopia in
one case.
Point mutations are found in syn-
dromes presenting HPE. The OMIM
database (http://www.ncbi.nlm.nih.-
gov/omim/), visited on March 30th,
2011) presented 31 syndromes showing
HPE (Table I). A careful review of them
shows that only four, the dysgnathia
complex (or agnathia–HPE or otoce-
phaly) (OMIM 202650), the Pseudo-
trisomy 13 syndrome (OMIM 264480),
the Steinfeld syndrome (OMIM
184705); and the Smith–Lemli–Opitz
syndrome (OMIM 270400), had cyclo-
pia [Atkin, 1988; Cohen and Gorlin,
1991; No¨then et al., 1993; Rolland
et al., 1991; Weaver et al., 2010]. Also,
only these four syndromes plus osteopa-
thia striata with cranial sclerosis (OMIM
300373) presented with the alobar type
of HPE. There are descriptions of other
syndromes presenting HPE in the litera-
ture, as Rubinstein–Taybi syndrome,
Meckel syndrome [Hsia et al., 1971], and
Martin syndrome [Martin et al., 1977],
not disclosed in Table I, since they are
not associated with HPE in the OMIM
database (Table I).
Some cyclopia patients present
with one or more unrelated congenital
anomalies that are not part of the non-
chromosomal syndromes cited above.
Concurrence of cyclopia and sirenome-
lia in the same patient was reported by
Martı´nez-Frı´as et al. [1998], while
associations of both defects with similar
epidemiological risk factors were found
by Ka¨lle´n et al. [1992]; involvement in
the same clusterswas reported byCastilla
et al. [2008], and sharing of a similar
pathogenetic mechanism was noted by
O’Railly and Mu¨ller [1989].
Classification and Nomenclature
Aclassical paper,whose title humorously
and intelligently, two conditions rarely
found in medical literature, proposed
that ‘‘The face predicts the brain’’ was
published by DeMyer et al. [1964].
However, as science has no room for
poetic licenses, this publication was
criticized based on reported patients
which did not fit into this axiom [Olsen
et al., 1997; Plawner et al., 2002], while
Cohen [1989b] quantified the excep-
tions to the rule, concluding that the
proportion of patientswhere the face did
not predict the brain comprised from 10
to 39% of all HPE patients [Levey et al.,
2010].
From the anatomo-pathological
point of view, three types of HPE were
described by DeMyer and Zeman
[1963], in decreasing severity: alobar,
semilobar, and lobar; while clinically the
following types were proposed with
certain degree of correspondence with
the brain anatomy [DeMyer et al., 1963]:
(1) Medial monophtalmia with arrhinia
and proboscis (cyclopia), (2) ethmoce-
phaly with supra-orbital proboscis,
Cyclopia is an etiologically
heterogeneous condition, which
can result from chromosomal
defects, genetic mutations or
environmental teratogenic
factors.
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TABLE I. Syndromes That Could Present Holoprosencephaly (HPE) Among Their Clinical Features According to OMIM
(Online Mendelian Inheritance in Man)
MIM IDa Syndrome
Chromosome
region Gene
Alobar
type Cyclopia Notes
% 202650 Dysgnathia complex — — Yes Yes Ciliopathy
264480 Pseudo-trisomy 13 — — Yes Yes AR? Microdeletion?
184705 Steinfeld — — Yes Yes AD
# 276400 Smith–Lemli–Opitz 11q12–q13 DHCR7 Yes Yes AR
# 300373 Osteopathia striata with
cranial sclerosis
Xq11.1 WTX Yes No LXD
# 176450 Currarino 7q36 HLXB9 No No Microdeletion?
# 147791 Jacobsen, Chr. 11q deletion 11q23 — No No Microdeletion
% 129900 EEC 1 7q11.2–q21.3 — No No —
# 236680 Hydrolethalus 1 11q24.2 HYLS1 ? No —
% 612776 Hypoglossia with situs
inversus
— — No No Mild form of agnathia-HPE?
þ 187395 Teratocarcinoma derived
growth factor 1
3p23–p21 TDGF1 No No Only 1 paperb
% 605627 Cerebrooculonasal PTCH? No No HPE7?
# 192430 Velocardiofacial 22q11.2 TBX1 No No Only 1 paperb
187100 Supernumerary teeth,
mesiodens
— — No No —
# 147950 Kallmann 2 — FGFR1 No No —
300706 Mental retardation XL Xp11.2 HUWE1 No No XL
303073 Fetal akinesia XL — — No No XL
# 253800 MDDGA4, Walker–
Warburg
9q31 FKTN No No AR, dystroglycanopathy
# 214800 Charge 8q12.1
7q21.11
CHD7
SEMA3E
No No —
# 206900 Microphtalmia and
esophageal atresia
3q26.3–q27 SOX2 No No Only one paperb
þ 180200 Retinoblastoma 13q14.1–q14.2 RB1 No No Del 13q14?
156810 Microgastria-limb
reduction
— — No No —
300571 Hartsfield — — No No —
601370 Genoa — — No No AR?
306990 HPE with fetal akinesia — — No No XL?
610680 HPE, recurrent infection,
monocytosis
— — No No AD?
245552 Lambotte — — No No —
146510 Pallister–Hall 7p13 GLI3 No No —
601357 Amelia, forebrain defects,
and clefts
— — No No —
612651 Endocrine
cerebroosteodysplasia
6p12.3 ICK No No —
% 600674 Microtia anotia — — No No —
a(þ) genewith known sequence and phenotype; (#) phenotype description,molecular basis known; (%)mendelian phenotype or molecular
basis unknown; (none) other, mainly phenotype with suspected mendelian basis. MIM: Online Mendelian Inheritance in Man number.
bOnly one paper described HPE in the condition.
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(3) hypotelorism, inter- or infra-orbital
proboscis with single nostril (ceboce-
phaly), (4) median cleft of the upper lip
with agenesis of premaxilla (with HPE
obviously).
Proboscis refers to a blind-ending
tube-like structure at or near themidline
of the face, and can be supra or infra
orbital, synophthalmia refers to merged
ocular globes with variable degrees of
fused ocular structures. Synophtalmia is
sometimes used as cyclopia synonym as
pointed out by Cohen and Sulik [1992]
or to mean fused eyes in one orbit, as
used by Solomon et al. [2010]. Since this
is not a real fusion but rather a defect
in the patterning of the eye fields,
synophtalmia could be a misleading
term. The origin of the word cyclopia
is also controversial and itmight not even
mean one-eyed people.
Cyclopia represents between 10%
[Orioli and Castilla, 2007] and 20%
[Mastroiacovo et al., 1992] of all HPE
as reported by the two largest pub-
lished series, the difference being prob-
ably due to variation in phenotypic
documentation.
Epidemiology (Includes
Prevalence, and Risk Factors,
Known or Hypothetical)
In a recent reviewof HPE epidemiology
[Orioli andCastilla, 2010], that included
prevalence and risk factors, 24 HPE
published series around the world were
reviewed. Two years before, HPE data
from 24 of the 46 Birth Defects Registry
Members of the International Clearing-
house for Birth Defects Surveillance and
Research (ICBDSR) [Leoncini et al.,
2008] were also analyzed. Thirteen
members of the ICBDSR also partici-
pated in the unique epidemiology study
dealing onlywith cyclopias [Ka¨lle´n et al.,
1992]. From these three studies, we
concluded that there are several factors
to explain the observed epidemiologic
differences in maternal age, twinning
rate and sex among the studied popula-
tions. Operational factors as the different
proportions of embryos, fetuses, still-
borns, and liveborns in each studied
population will result in different pro-
portions of HPE caused by chromoso-
mal abnormalities. The younger the
patients the higher the prevalence of
chromosomal abnormalities. Then, var-
iables such as maternal age and other
associated with it will change accord-
ingly.
In regard to specific environmental
risk factors, Cohen and Shiota [2002]
reviewed several factors, including ethyl
alcohol, diabetic embryopathy, retinoic
acid, and several anecdotal suggestions of
teratogenic factors for HPE, including
viruses, and salicylates. Orioli and Cas-
tilla [2007] confirmed in a South
American series maternal diabetes and
maternal flu as more prevalent in HPE
than in controls. Miller et al. [2010]
analyzed case patients and controls from
the National Birth Defects Prevention
Study and found HPE to be associated
with pre-existing diabetes, aspirin use,
lower education level, and use of assisted
reproductive technologies. In the same
issue, Johnson and Rasmussen [2010]
provided a summary of nongenetic risk
factors for HPE that have been investi-
gated in case reports and case series,
animal studies, and epidemiologic stud-
ies, including maternal illnesses, thera-
peutic and nontherapeutic exposures,
nutritional factors, and sociodemo-
graphic factors.
METHODS
Birth defects surveillance programs that
are part of ICBDSR were asked to
provide de-identified case records fol-
lowing a common protocol, with infor-
mation on phenotype, genetic testing,
and selected demographic and prenatal
information. Further details on the
methodologies can be found in Castilla
and Mastroiacovo [2011] in this issue.
As part of the Very Rare Defect study of
the ICBDSR, 20 surveillance programs
in 25 countries (10 countries repre-
sented in Estudo Colaborativo Latino
Americano de Malformac¸o˜es Congeˆni-
tas: ECLAMC), from North and South
America, Europe, Israel, China and
Australia provided data on cyclopia from
an underlying cohort of 25.6 million
births. The years represented were
1968–2006, depending on the reporting
site.
Clinical and demographic datawere
reviewed centrally by two authors with
experience in dysmorphology (IO and
PM). Additional information for in-
clusion or exclusion of cases was also
requested in a second step by one
author (IO). After the identification of
all chromosomal and nonchromosomal
syndromes, the remaining cases with
multiple congenital anomalies (MCA)
were classified according to the number
of unrelated defects to the HPE spec-
trum [Orioli and Castilla, 2007], and
according to the presence of postaxial
polydactyly. All cases were reported by
verbatim description, and centrally clas-
sified without coding. Nevertheless in
222 of the 257 patients (86%), the defect
was reported by a single word (i.e.,
cyclopia), therefore consisting of just a
naming rather than of a real description.
In 35 cases more details were provided
on theHPE type, and/or the presence of
proboscis, and/or the number of eyes
inside the orbit.
Occurrence was expressed as total
prevalence [number of live births, still-
births and elective termination of preg-
nancy for fetal anomaly (ETOPFA) with
cyclopia per 100,000 births] with its
95% confidence intervals (CI). For each
program the expected number of cases
was calculated under the hypothesis of a
homogeneous prevalence among all
programs. Using the expected values
we calculated the exact Poisson proba-
bilities of observing N or more cases
[P(N x)] in each registry. Maternal
age-specific prevalence ratios were cal-
culated across several clinical subtypes
(isolated, MCA, and chromosomal
Proboscis refers to a
blind-ending tube-like
structure at or near the midline
of the face, and can be supra or
infra orbital, synophthalmia
refers to merged ocular globes
with variable degrees of fused
ocular structures.
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syndromes) with women <20 years of
age serving as the referent group. Odds
ratios and 95%CI were computed across
clinical subtypes to examine the associa-
tion of various characteristics using both
isolated and MCA as a referent group.
Pearson correlation was used as a
measure of correlation between the
prevalence of cyclopia and twovariables:
the number of births and the proportion
of ETOPFA in each registry. The 95%CI
were computed using the Poisson distri-
bution. Statistical tests significance was
set to P< 0.05. Statistical analyses were
done with Stata software, version 10.0
[StataCorp., 2007].
RESULTS
Prevalence
The total number of births and of
cyclopia cases is given in Table II for
each one of the 20 surveillance programs
members of the ICBDSR. A total of 257
infants with cyclopia were identified
among 25,580,661 births, giving a total
prevalence of 1.0 per 100,000 births
(95%CI: 0.89–1.14).
About half (54.0%) of the cases with
cyclopia in this study were provided by
four reporting surveillance programs:
South America ECLAMC, France
Central East, China Beijing, and USA
Texas.
ETOPFA is not permitted for
two surveillance programs (Mexico
RYVEMCE: Registro y Vigilancia
Epidemiolo´gica de Malformaciones
Conge´nitas, and South America
ECLAMC). Furthermore, it was not
recorded in two other surveillance
programs (Spain ECEMC: Spanish
Collaborative Study of Congenital
Malformations, and China, Beijing),
and was recorded at an unknown and
probably variable ascertainment rate in
the rest.
Figure 1 compares estimates of
the cyclopia prevalences with their
95%CI among the different surveillance
programs. Only Hungary’s prevalence’s
upper confidence limit was below the
total prevalence of 1.0 per 100,000
births suggesting under-registration
(0,26 per 100,000; CI: 0.11–0.52,
P< 0.0001). Excluding this program,
the overall prevalence of 1.10 per
100,000 is estimated for all the re-
maining programs, with a marginal
statistically significant higher pre-
valence estimated in Italy North-East
(1.77, CI: 1.10–2.71). There was no
correlation between the cyclopia
prevalence and number of births
(r¼ 0.08; P¼ 0.75) or proportion of
elective termination of pregnancy
(r¼0.01; P¼ 0.97) in each surveil-
lance program.
TABLE II. Total Prevalence (Per 100,000 Births) of Cyclopia in 20 Surveillance Programs Members of the International
Clearinghouse for Birth Defects Surveillance and Research (ICBDSR)
Surveillance program Period Births
Total
cases
% of
ETOPFA
Prevalence
(per 100.000 births) 95%CI
Canada Alberta 1980–2005 1,062,483 9 0 0.85 0.39–1.61
USA Utah 1997–2004 380,706 2 50.0 0.53 0.06–1.90
USA Atlanta 1968–2004 1,283,999 13 38.5 1.01 0.54–1.73
USA Texas 1996–2002 2,054,788 25 32.0 1.22 0.79–1.80
Mexico RYVEMCE 1978–2005 1,058,885 18 NP 1.70 1.01–2.69
South America ECLAMC 1982–2006 4,556,173 55 NP 1.21 0.91–1.57
Finland 1993–2004 713,494 8 50.0 1.12 0.48–2.21
Wales 1998–2004 222,309 5 40.0 2.25 0.73–5.25
Northern Netherlands 1981–2003 369,658 3 0 0.81 0.17–2.37
Germany Saxony-Anhalt 1980–2004 355,184 3 100 0.84 0.17–2.47
Slovak Republic 2000–2005 318,257 1 100 0.31 0.01–1.75
Hungary 1980–2005 3,022,194 8 0 0.26 0.11–0.52
France Central East 1979–2004 2,500,214 30 56.7 1.20 0.81–1.71
Italy North East 1981–2004 1,186,497 21 47.6 1.77 1.10–2.71
Italy Tuscany 1992–2004 336,744 2 50.0 0.59 0.07–2.15
Italy Campania 1992–2004 643,962 2 50.0 0.31 0.04–1.12
Spain ECEMC 1980–2004 2,045,751 14 NR 0.68 0.37–1.15
Israel 1975–2005 151,562 1 0 0.66 0.02–3.68
China Beijing 1992–2005 1,927,622 29 NR 1.50 1.01–2.16
Australia Victoria 1983–2004 1,390,179 8 50.0 0.58 0.25–1.13
25,580,661 257 40.4 1.00 0.89–1.14
RYVEMCE, Registro y Vigilancia Epidemiolo´gica de Malformaciones Conge´nitas; ECLAMC, Estudo Colaborativo Latino Americano
de Malformac¸o˜es Congeˆnitas; ECEMC, Spanish Collaborative Study of Congenital Malformations; ETOPFA, elective termination of
pregnancy for fetal anomaly; NP, not permitted; NR, not reported.
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Secular Variation and Clustering
of Cases
The rarity of cyclopia induces great
variation in the annual frequencies
within each one of the 20 programs
without evident secular trends in any
program. None of the programs
reported an evidence of a cluster of cases.
Maternal Age
Maternal age was not specified in 9.8%
of the total births and in 18.4% of the
cases with cyclopia. Maternal age was
analyzed by 5-year groups in 19 pro-
grams by clinical phenotypes: isolated,
MCA, and chromosomal abnormalities.
Figure 2 shows that cases with chromo-
somal abnormalities presented a statisti-
cally significant increasing trend
(P¼ 0.015), as expected. The MCA
case group did not show any maternal
age trend, but the oldest mothers
(>40 years of age) had a prevalence that
was over four times the prevalence
among the referent group of youngest
mothers (<20 years of age) (prevalence
ratio 4.33, 95%CI: 1.16–16.12). Iso-
lated cases did not present any maternal
age effect, These results suggest that a
number of undiagnosed cases of chro-
mosomal trisomies could be present
within the MCA group, but not within
the isolated group.
Cases’ Characteristics by Clinical
Phenotype
Chromosomal syndromes. Therewere 79
cases with chromosomal syndromes,
accounting for 31% of the cyclopias.
Only 23% of total cases had an available
karyotype, since karyotyping was not
done or reported in all cases. Given the
limited reporting on karyotypes, it is
possible that the estimate of chromo-
somal syndromesmay be higher than the
31% referred here. For example, two
South American associated cases left
out from the chromosomal syndromic
group in the material presented here,
were later on proved to have a chromo-
somal anomaly by multiplex ligation-
dependent probe amplification (MLPA)
analysis. Most of these 81 cases (79þ 2)
were trisomy 13 (n¼ 68; 84%), followed
by trisomy18 (n¼ 6) or partial short arm
monosomy (n¼ 3) (subtotal n¼ 9;
10%). In addition there were two cases
with triploidy, one with trisomy 21, and
one with a partial deletion of 7q36.
The main characteristics of chro-
mosomal syndromes are shown in
Table III. The proportion of males
(0.47) did not differ from the expected
in the 78 specified cases. More than half
of cases are stillborn or submitted to
ETOPFA, and almost 80% have low
birth weight.
The comparison of the character-
istics of chromosomal syndrome cases
versus isolated andMCAcases are shown
in Table IV, where the odds ratios of the
possible ‘‘risk factors’’ (characteristics)
with their 95%CI were computed using
both isolated and MCA as a referent
group. In this analysis only programs
with less than 20% of unknown infor-
mation were used. The occurrence of an
elective termination (or ETOPFA) was
approximately 3.5 times more likely
among chromosomal cases than isolated
Figure 1. Total prevalence per 100,000 births (bar) and 95% confidence interval
(line) by surveillance program and overall (dotted line) of cyclopia in 20 surveillance
programsmembers of the International Clearinghouse for BirthDefects Surveillance and
Research (ICBDSR).
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cases (OR¼ 3.48, 95%CI: 1.53–7.90).
No significant associations were found
when chromosomal cases were com-
pared with MCA cases.
Multiple congenital anomalies (MCA).
There were 81 cyclopia cases (31%)
with associated defects not usually con-
sidered as part of the HPE spectrum. As
mentioned before, we expected that
with all cases fully analyzed for chromo-
somal abnormalities this proportion
could be lower. When grouping these
cases according the number of non-
related HPE defects, 45 had only one
associated defect (55%), 19 had two
(24%), and 17 (21%) had three, four, or
five associated defects. Most of these
associated defects were similar to the
ones found in the chromosomal
syndromes, mainly omphalocele, anal
atresia, cardiac, renal, and postaxial
polydactyly. Postaxial polydactyly was
present in 22/81 (27%) of the MCA
cases. Different from the chromosomal
syndromes, this group presented more
cases with heterotaxia defects (6/81),
neural tube defects (10/81), and preaxial
limb reduction defects (9/81). Few
nonchromosomal syndromes or associa-
tions could be suspected among the
MCA cases: there were two cases with
otocephaly—HPE, and two less typical
examples of the dysgnathia complex,
one case of prune belly, one case of
VATER association with hydrocepha-
lus, one chondrodystrophy not further
specified, and one case of cyclopia and
sirenomelia in the same case. This last
case, according to the partial description,
probably was a case with cyclopia,
sirenomelia, and acardia-acephaly. The
defects presented by some of these cases
are displayed in Box I.
The main characteristics of the
MCA cases are shown in Table III. The
proportion of male (M/T¼ 0.41) ob-
served did not differ from the expected.
More than half of cases were stillborn or
submitted to ETOPFA.
Comparing these characteristics
with the isolated cases (the comparison
with chromosomal syndromes is given
above) revealed only one marginal
statistical association with ETOPFA
(OR¼ 2.52; 95%CI: 1.07–5.94).
Isolated cases. The main characteristics
of isolated cases are shown in Table III.
The proportion of males (0.38) was
statistically significant different from
the expected (w2¼ 6.53; P< 0.05).
More than half of cases were liveborn,
and more than 50% have low birth
weight.
DISCUSSION
Prevalence
The cyclopia prevalence 1.0 per 100,000
births (CI: 0.89–1.14) found in over 25
million births did not differ from 1.03
found previously by Ka¨lle´n et al. [1992]
Although both series of data came from
the Clearinghouse, there were data
overlapping only for theMexican, South
American, Spanish, and French regis-
tries. The other 16 registries did not
participate in the former work [Ka¨lle´n
et al., 1992].
Cyclopia has been reported as
between 10% and 18% of the HPE
published series, as revised by Orioli and
Castilla, [2010]. There are two epidemi-
ologyworks about HPE using the Kyoto
Collection of Embryos [Matsunaga and
Shiota, 1977; Yamada et al., 2004],
however only 11 embryos at Carnegie
stage 8–21 had facial anomalies de-
scribed in the last work. Two embryos
presented complete cyclopia and three
presented partially fused eyes in a
single eye fissure, elevating the propor-
tion of cyclopias among HPE to 45% in
embryos.
Few studies report on the propor-
tion of cyclopias or HPE among trisomy
13 patients. Ka¨lle´n et al. [1992] found
8 cyclopias in 436 (1.8%), and Wyllie
et al. [1994] found one HPE among 36
trisomy 13 patients (2.8%). Considering
a recent estimate of trisomy 13 preva-
lence of 0.14/1,000 (0.12–0.17) [Irving
et al., 2011] we would have expected
3,581 patients of trisomy 13 among the
25,580,661 births, and also expected 99
cyclopias with trisomy 13. However, we
detected only 68 cyclopia cases (69%)
with trisomy 13.
Clustering of Cases
None of the reporting programs, includ-
ing South America, reported evidence
of a cluster of cases. A significant cluster
Figure 2. Prevalence ratios for maternal age groups relative to the reference age
group of<20 years with corresponding 95%CI, for cyclopia in 20 surveillance programs
members of the International Clearinghouse for BirthDefects Surveillance andResearch
(ICBDSR).
The cyclopia prevalence 1.0 per
100,000 births (CI: 0.89–1.14)
found in over 25 million births
did not differ from 1.03 found
previously by Ka¨lle´n et al.
[1992]
.
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TABLE III. Characteristics of the Cases With Cyclopia
Total cases
(n¼ 257)
Isolated cases
(n¼ 97)
Cases with associated
malformations (n¼ 81)
Chromosomal syndromes
(n¼ 79)
n % n % n % n %
Sex
Male 103 40.1 36 37.1 30 37.0 37 46.8
Female 143 55.6 59 60.8 43 53.1 41 51.9
Indeterminate 6 2.3 0 0.0 6 7.4 0 0.0
Missing data 5 2.0 2 2.1 2 2.5 1 1.3
Outcome
Livebirths 122 47.5 51 52.6 35 43.2 36 45.6
Stillbirths 78 30.4 35 36.1 27 33.3 16 20.3
ETOPFA 57 22.2 11 11.3 19 23.5 27 34.2
Missing data
Birth weight (g)a
<1,500 32 26.2 11 21.6 14 40.0 7 19.4
1,500–2,500 59 48.4 25 49.0 13 37.1 21 58.3
>2,500 26 21.3 14 27.5 7 20.0 5 13.9
Missing data 5 4.1 1 2.0 1 2.9 3 8.3
Gestational age (week)a
<32 21 17.2 9 17.7 8 22.9 4 11.1
32–36 52 42.6 19 37.3 13 37.1 20 55.6
37 41 33.6 20 39.2 11 31.4 10 27.8
Missing data 8 6.6 3 5.9 3 8.6 2 5.6
Parity
0 35 13.6 18 18.6 12 14.8 5 6.3
1 93 36.2 40 41.2 29 35.8 24 30.4
2 or more 39 15.2 15 15.5 11 13.6 13 16.5
Missing data 90 35.0 24 24.7 29 35.8 37 46.8
Previous spontaneous abortions
0 81 31.5 29 29.9 27 33.3 25 31.7
1 14 5.5 5 5.2 5 6.2 4 5.1
Missing data 162 63.0 63 65.0 49 60.5 50 63.3
Plurality
Single 225 87.6 87 89.7 70 86.4 68 86.1
Twin 6 2.3 2 2.1 2 2.5 2 2.5
Missing data 26 10.1 8 8.3 9 11.1 9 11.4
Maternal age
<20 18 7.0 9 9.3 5 6.2 4 5.1
20–24 63 24.5 20 20.6 28 34.6 15 19.0
25–29 63 24.5 29 29.9 17 21.0 17 21.5
30–34 47 18.3 16 16.5 12 14.8 19 24.1
35–39 28 10.9 11 11.3 8 9.9 9 11.4
40 8 3.1 1 1.0 4 4.9 3 3.8
Missing data 30 11.7 11 11.3 7 8.6 12 15.2
Parental age difference
Mother same age or older 22 8.6 10 10.3 7 8.6 5 6.3
Mother 1–2 years younger 24 9.3 9 9.3 9 11.1 6 7.6
Mother 3–5 years younger 24 9.3 8 8.3 11 13.6 5 6.3
Mother >5 years younger 14 5.5 5 5.2 4 4.9 5 6.3
Missing data 173 67.3 65 67.0 50 61.7 58 73.4
Maternal education (years)
<9 20 7.8 7 7.2 12 14.8 1 1.3
9 or more 52 20.2 26 26.8 15 18.5 11 13.9
Missing data 185 72.0 64 66.0 54 66.7 67 84.8
aBirth weight, gestational age: the data are for live births only.
of sirenomelia and cyclopia in the city
of Cali, Colombia [Castilla et al.,
2008], was not reflected in the South
American material presented in this
present work since the four cases of
cyclopia born in Cali in 2005 were
diluted when merged together with
another 243 cases from other South
American cities and periods. This exem-
plifies well the need for active ongoing
surveillance of the collected data, which
allowed the ECLAMC program to
detect the cluster within a few weeks
after the fourth case of this epidemic
was born. When active surveillance is
TABLE IV. Odds Ratios (OR) of the Association of the Various Characteristics of: (A) Multiple Congenital Anomalies
(MCA) Cases Compared to Isolated, (B) Chromosomal Syndromes Compared to Isolated, and (C) Chromosomal
Syndromes Compared to MCA Cases
(A) MCA vs.
isolated cases
(B) Chromosomal syndromes vs.
isolated cases
(C) Chromosomal syndromes
vs. MCA
Crude
OR 95%CI
Crude
OR 95%CI
Crude
OR 95%CI
Sex
Male 1.00 1.00 1.00
Female 0.87 0.47 1.63 0.68 0.37 1.24 0.77 0.41 1.47
Outcome
Livebirths 1.00 1.00 1.00
Stillbirths 1.12 0.58 2.18 0.65 0.31 1.34 0.58 0.26 1.25
ETOPFA 2.52 1.07 5.94 3.48 1.53 7.90 1.38 0.65 2.92
Birth weight (g)a
<1,500 2.54 0.76 8.47 1.78 0.44 7.18 0.70 0.16 3.02
1,500–2,500 1.04 0.34 3.21 2.35 0.73 7.61 2.26 0.59 8.64
>2,500 1.00 1.00 1.00
Gestational age (week)a
<32 1.62 0.48 5.38 0.89 0.22 3.61 0.55 0.12 2.40
32–36 1.24 0.45 3.45 2.10 0.79 5.64 1.69 0.56 5.11
37 1.00 1.00 1.00
Parity
0 1.00 1.00 1.00
1 0.30 0.08 1.10 0.50 0.12 2.08 1.65 0.48 5.68
2 or more 0.28 0.07 1.21 0.63 0.13 2.91 2.20 0.54 8.96
Previous spontaneous abortions
0 1.00 1.00 1.00
1 or more 1.17 0.18 7.79 1.50 0.25 9.11 1.28 0.26 6.34
Plurality
Single 1.00 1.00 1.00
Twin 1.24 0.17 9.05 1.28 0.17 9.32 1.03 0.14 7.52
Maternal age
<20 1.00 1.00 1.00
20–24 2.52 0.73 8.66 1.69 0.43 6.54 0.67 0.16 2.87
25–29 1.05 0.30 3.67 1.32 0.35 4.94 1.25 0.28 5.47
30–34 1.35 0.36 5.08 2.67 0.69 10.33 1.98 0.44 8.87
35–39 1.31 0.31 5.43 1.84 0.42 8.01 1.41 0.28 7.13
40 7.20 0.62 83.34 6.75 0.53 86.56 0.94 0.13 6.87
Parental age difference
Mother same age or older 0.70 0.18 2.66 0.75 0.17 3.33 1.07 0.23 5.02
Mother 1–2 years younger 1.00 1.00 1.00
Mother 3–5 years younger 1.37 0.38 5.03 0.94 0.20 4.29 0.68 0.15 2.99
Mother >5 years younger 0.80 0.16 3.99 1.50 0.30 7.53 1.87 0.35 9.98
Surveillance programs where missing data were more than 20% were excluded from the analysis
aBirth weight, gestational age: the data are for live births only.
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routinely working, the cluster is first
suspected as a rumor that arises by an
‘‘alert practitioner’’ who was part of an
epidemiology system, capable of follow-
ing up on the rumor.
Maternal Age
As an important proportion of cyclopias
(29%) are associated with trisomy, with
an expected increased maternal age
among deliveries, we expected a higher
proportion of older age mothers among
the cyclopia patients. However, the
increased rate of cyclopias seen in the
older maternal age groups (above
29 years old) in the total sample was
not statistically significant. Only moth-
ers 40 years old or above in the MCA
group were in excess with respect to
the mothers in the range <20. This
suggests two possible explanations: (1)
there is a substantial number of trisomy
cases under-diagnosed among the MCA
nonchromosomal group; and (2) a
maternal age effect in trisomy 13 is
not as important as the maternal age
effect reported in other trisomies, as
trisomy 18, for example [Crider et al.,
2008].
Twinning
Only 6 from 231 infants with cyclopia
were twins (2.6%). This low frequency
of twinning differs from the excess of
twinning reported by Ka¨lle´n et al.
[1992]. The greater size of the present
sample (25.6 million births) compared
with the sample size used by Ka¨lle´n et al.
[1992] (10.1 million births) could be an
explanation.
Sex
Mastroiacovo et al. [1992], Rasmussen
et al. [1996], and Orioli and Castilla
[2010] did not confirm the excess of
females among HPE patients as
described in other series. The excess of
female patients among cyclopias as seen
in our work among the isolated cases or
in Ka¨lle´n et al. [1992], or in other
previous HPE series [Roach et al., 1975;
Croen et al., 1996, 2000; Forrester and
Merz, 2000; Chen et al., 2005] could be
attributed to the excess loss of male
embryos through spontaneous abortion
[Rasmussen et al., 1996]. This idea was
founded on studies of HPE in embryos
[Matsunaga and Shiota, 1977], who
showed a much higher rate of HPE than
in newborns, and also on studies of
fetuses with HPE, where an equal sex
ratio or even a male excess could be
observed [Blaas et al., 2002]. The lack of
sex difference in the MCA, chromoso-
mal syndromes and ETOPFA samples in
the present work is consistent with this
hypothesis, as well as the already men-
tioned presence of undetected chromo-
some syndrome patients in the MCA
group.
Nonchromosomal Syndromes or
Associations
In Table I are presented 31 syndromes
that, with three possible exceptions,
are nonchromosomal syndromes. The
exceptions are pseudo-trisomy 13
BOX 1. Defects Described in Six Cases With Cyclopia
ID Defects Karyotype Diagnoses hypotheses
1 Cyclopia; alobar HPE; microcephaly; external hydrocephaly; arhinia;
microstomia; prominent ears; anomalous mandible; esophageal atresia;
thoracic hemivertebras; butterfly vertebras; anomalous pelvic bone;
preaxial polydactyly; polyhydramnion
46,XX OMIM # 276950 VATER with
hydrocephalus
2 Cyclopia; unspecified septal ventricular defect; polycystic kidneys adult
type; anomalies of hand (lobster claw hand); Arthrogryposis multiplex
congenital
— OMIM 200980
Acrorenal-mandibular
with HPE
3 Cyclopia; microcephalus; jaw defect; microtia; preauricular appendage;
microstomia; Meckel diverticulum; radius absent
— OMIM % 202650 Dysgnathia
complex? Ciliopathy?
4 Cyclopia; proboscis above eye; otocephaly; micropene; bilateral
criptorquidia; pilonidal pit
— OMIM % 202650 Dysgnathia
complex
5 Cyclopia, partially fused eyes; proboscis above eyes; alobar HPE; arhinia;
microstomia; mouth could not be open; microtia; missing first, second
and thirds fingers bilaterally; feet syndactyly between second and third
right toes and between third and fourth left toes; bilateral agenesis of
radius; anal atresia; ambiguous genitalia; pulmonary isomerism;
polisplenia; heart and abdominal organs in the midline (situs
ambiguous); ovaries and uterus didelphus; one pelvic kidney with two
short ureteres
46,XX OMIM % 202650 Dysgnathia
complex? Ciliopathy?
6 Cyclopia; alobar HPE; mandible agenesis; microtia grade 1; melotia;
preauricular fistula; absent mouth; absent tongue; pharyngeal stenosis;
hypoplastic lungs; hypoplastic adrenal glands
46,XX OMIM % 202650 Dysgnathia
complex
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(HPE-polydactyly), Currarino syn-
drome, and Jacobsen syndrome that
could be caused by microdeletions on
chromosome 13, 7q36, and 11q chro-
mosomal regions, respectively. We scru-
tinized the 81 patients in the MCA
group looking for examples of these
syndromes without much exit. Several
cases could be suspected of trisomy 13 or
of pseudo-trisomy 13,mainly thosewith
postaxial polydactyly. Few were sus-
pected of other nonchromosomal syn-
dromes has can be viewed in Box I.
It is out of the scope of this work
to confirm the suggested diagnoses in
Box I. However, the two otocephaly or
agnathia-HPE patients have clear diag-
noses. A recent otocephaly review
[Faye-Petersen et al., 2006] shows an
otocephaly prevalence around 1:70,000
births and reported that half of them
present HPE. Since a conservative esti-
mate of cyclopia among HPE is 10%, we
must expect 18 patients with cyclopia-
otocephaly association in our material
{[(25,580,661/70,000)/2]/0.10}. The
poor description observed in 86% of
our cases with cyclopia could explain
why we identify only 10% of the
expected number of this association.
There is another possible reason to
explain the few examples of syndromes
we found in our MCA material. A
careful review of the type of HPE
associated with each one of those 31
syndromes in Table I shows that only the
first four were ever associated with
alobar HPE and with cyclopia: dysg-
nathia complex (OMIM 202650), pseu-
do-trisomy 13 (OMIM 264480),
Steinfeld syndrome (OMIM 184705),
and Smith–Lemli–Opitz syndrome
(OMIM 276400).
The interesting case with cyclopia,
sirenomelia, and acardia-acephaly was
not found previously described in the
literature. However, several patients
reviewed by Siebert [2007] presented
cerebral defects as cyclopia, apros-
encephaly, or atelencephaly with acar-
diac twinning. Hypoxia-ischemia due to
twin reversed arterial perfusion (TRAP)
is a common explanation for these
defects and probably can explain the
presence of sirenomelia in our present
case. Acardia-acephaly with sirenomelia
is also a combination of two very rare
defects already published [Martı´nez-
Frı´as, 2009; Orioli et al., 2011, this
issue].
Ultimately, a new type of patho-
genesis, the ciliopathies, have been
proposed to explain a large number of
diseases, mainly heterotaxia defects,
hydrocephaly, neural tube defects, and
other defects related to twining [Hilde-
brandt et al., 2011]. Six patients within
the MCA group of cyclopias presented
with these kind of heterotaxic defects
as accessory spleen, situs inversus, situs
ambiguous, and lung isomerism; 6
presented with hydrocephalus, and 10
presented with NTD. With the excep-
tion of hydrocephalus, these defects
were not found in excess among a
South American HPE series [Orioli
and Castilla, 2007]. We cannot test the
statistical significance of this excess in
our cyclopia sample; however, only 2
cases with bilobar lung, and no cases
with hydrocephalus or NTD occurred
in the chromosomal anomaly group of
79 patients. Also, only one patient with
preaxial reduction defect was seen in the
chromosomal group. There are several
phenotypes associated with cilia dys-
function in mammals including ran-
domization of the left–right body axis,
abnormalities in neural tube closure and
patterning, skeletal defects such as poly-
dactyly, etc. A new locus for Meckel
syndrome (MK8), a diagnosis that can be
confounded with trisomy 13, was de-
scribed [Shaheen et al., 2011], and map
to TCTN2 a paralog for Tectonic 1,
which was involved in Sonic Hedgehog
(SHH) signaling. SHH has been de-
scribed as one of the most important
genes causing HPE what reinforces the
possible causal role of ciliopathies in the
cyclopia causation.
Are Cyclopias Different From
HPE?
Since cyclopias are rare, there are
difficulties in collecting enough patients
to compare epidemiologicallywithHPE
in general. In this work a sample of 257
cyclopias could be analyzed and no
important differences were demon-
strated with respect to HPE [Mastroia-
covo et al., 1992; Orioli and Castilla,
2007; Orioli and Castilla, 2010].
Although the analyses of environmental
factors was limited by missing data, the
available data show one patient of
mother with diabetes, no patients of
alcoholic mothers, two patients born
after threatened abortion, one using
misoprostol and one not further speci-
fied, and a half dozen patients born after
maternal flu or fever, among a few other
gestational exposures. In general, these
limited findings agree with previous
HPE epidemiological data reviewed by
Orioli and Castilla [2010]. There are
several possible causes of HPE, but we
could not highlight any of them as more
important or more specific to cause
cyclopia. Only the pattern of associated
defects in the group MCA seems to
indicate a possible role of ciliopathy
disorders to explain some cases of cyclo-
pia.
CONCLUSION
The cyclopia prevalence of 1 per
100,000 (0.89–1.14) did not differ from
the previously published in the literature
and was similar among most of the
registries around the world. Neither
the proportion of cyclopias submitted
to ETOPFA, nor the number of births in
each surveillance program were corre-
lated with the cyclopia prevalence.
An important proportion of cyclo-
pias (31%) was associated with chromo-
somal anomalies, mainly trisomy 13.
Another 31% presentedwith defects that
are not related to HPE. This last group
also had more occurrences of other
defects, namely hydrocephalus, hetero-
taxic defects, NTDs, and preaxial reduc-
tion defects than the chromosomal
group, suggesting the presence of cil-
iopathies or other unrecognized syn-
dromes. The proportion of isolated cases
(38%) seems inflated, since in 86% of
these cases the defect was reported by
a single word (i.e., cyclopia), suggesting
the practice of naming rather than
providing a real description. Few non-
chromosomal syndromes or associations
could be suspected among the MCA
cases, probably because of the paucity of
the clinical descriptions.
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The prevalence of all cyclopias by
5-year maternal age groups was higher
among mothers in the two oldest age
groups (35–39 and 40 years old or
above), although this finding was not
statistically significant. There was an
expected increased prevalence with
maternal age in the chromosomal anom-
aly case group. The prevalence ratio for
the older maternal age group, relative
to the reference age group, was higher
and statistically significant in the MCA
group of cyclopias, suggesting a possible
contribution in this group with non-
recognized cases of trisomies.
The already described excess of
females in HPEwas seen for the cyclopia
casess, in livebirths, stillbirths, and in the
total sample, without sex differences in
the ETOPFA sample, MCA, and chro-
mosomal syndrome groups.
Cyclopia differ from other very rare
defects by the large contribution of
chromosomal anomalies to its etiology,
underlying the importance of the
chromosomal examination, direct or
through molecular techniques, in iso-
lated or in associated patients. Also
etiologically important are the nonchro-
mosomal syndromes, making the accu-
rate description of the phenotype,
including cerebral imaging, and careful
collection of familial history essential
requirements.When possible,molecular
studies should be performed since so
many genes are already associated to this
defect. Congenital defects registries
around the world must be aware of
the difficulty of gather this precious
material if the verbatim description are
the result of de-codification. The very
rare defects deserve, inside those regis-
tries, a special treatment, with detailed
phenotype descriptions and collection
of all possible familial information, in
order to improve future epidemiological
studies.
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